Werewolf Therapeutics Inc. Common Stock (HOWL)
About The Company
Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
IPO Year | Sector | Industry |
---|---|---|
2021 | Health Care | Biotechnology: Pharmaceutical Preparations |
Werewolf Therapeutics Inc. (HOWL) Latest News
Company Contact & Address (HOWL)
Corporate Headquarters | Phone | Website |
---|---|---|
1030 MASSACHUSETTS AVENUE SUITE 210, CAMBRIDGE, Massachusetts, 2138, United States |
+1 617 952-0555 | Official HOWL Website |
HOWL Key Executives
Ownership and management information.
Key Data Points*
Exchange | Not Available | Market Cap | Not Available |
---|---|---|---|
Sector | Health Care | P/E Ratio | Not Available |
Industry | Biotechnology: Pharmaceutical Preparations | Forward P/E 1 Yr. | Not Available |
1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
Today’s High/Low | Not Available | Annualized Dividend | Not Available |
Share Volume | Not Available | Ex Dividend Date | Not Available |
Average Volume | Not Available | Dividend Pay Date | Not Available |
Previous Close | Not Available | Current Yield | Not Available |
52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ HOWL
Jobs & Employment at Werewolf Therapeutics Inc.
LinkedIn Company Page | https://www.linkedin.com/company/werewolf-therapeutics |
---|---|
Official Career & Employment Page | Employment, Careers & Jobs at Werewolf Therapeutics Inc. (HOWL) |
Related & Similar Stock Symbols
![]() LIDRAEye Inc. Class A Common Stock
|
![]() HIGAH.I.G. Acquisition Corp. Class A …
|
![]() TSIBUTishman Speyer Innovation Corp. II Unit
|